Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Luisa Viterbo"'
Publikováno v:
Animals, Vol 13, Iss 20, p 3241 (2023)
The study aimed to investigate if arterial blood analysis in conscious horses presenting with signs of colic and breathing ambient air had diagnostic or prognostic value. Arterial blood samples from 352 horses presenting with colic at a university eq
Externí odkaz:
https://doaj.org/article/d7713f1885f84244b3ed7e3d1af84339
Autor:
Ana Espirito Santo, Sergio Chacim, Luis Leite, Isabel Cristina, Claudia Moreira, Dulcineia Pereira, Margarida Dantas, Marta Nunes, Luisa Viterbo, Angelo Martins, Ilidia Moreira, Isabel Oliveira, Nelson Domingues, Jose Mario Mariz, Rui Medeiros
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
BackgroundAcute MyeloidLeukemia is a clonal malignant disease, whit disappointing cure rates withcurrent treatment options. The authors’ intent to characterise acute myeloidleukaemia patients and to evaluate the outcome gain associated with the use
Externí odkaz:
https://doaj.org/article/61207fc73e494a019fcb9235cbeeec25
Publikováno v:
Veterinary Anaesthesia and Analgesia. 50:102-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3a6aeef728c13d98f780bebda756d5
https://doi.org/10.1016/j.vaa.2022.10.004
https://doi.org/10.1016/j.vaa.2022.10.004
Autor:
Rui Henrique, Ana Espirito-Santo, Isabel Oliveira, Ângelo Martins, Sérgio Chacim, Maria Eduarda Couto, Nelson Luís de Campos Domingues, Dulcineia Pereira, Cláudia Moreira, Jose Mario Mariz, Luisa Viterbo, Ilídia Moreira
Publikováno v:
Indian Journal of Hematology & Blood Transfusion
Gastric diffuse large B cell lymphoma (DLBCL) represents the majority of all gastric lymphomas. We report a series of gastric DLBCL diagnosed and treated in a single center, between 2010 and 2018 (included). We retrospectively analyzed the population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd75428f6d49fdb7eff8d61caac1302
https://doi.org/10.1007/s12288-020-01391-9
https://doi.org/10.1007/s12288-020-01391-9
Autor:
Luisa Viterbo, Ana Espirito Santo, Rui Henrique, Dulcineia Pereira, Jose Mario Mariz, Nelson Luís de Campos Domingues, Cláudia Moreira, Maria Eduarda Couto, Ângelo Martins, Sérgio Chacim, Ilídia Moreira, Isabel Oliveira
Publikováno v:
Indian J Hematol Blood Transfus
Gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma (gMALT NHL) is the second most common gastrointestinal lymphoma (50% of all gastric lymphomas), being closely associated with Helicobacter pylori infection, justifying that antibiotic the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62c8a84cbc70b87e52edea04b2586611
https://europepmc.org/articles/PMC9209548/
https://europepmc.org/articles/PMC9209548/
Autor:
Katarina Luptakova, Dixie Lee Esseltine, Jacob Zhang, Sunita Badola, Michele Cavo, Tamás Masszi, Jianchang Lin, Nizar J. Bahlis, Jonathan J Keats, Christian Langer, Shaji Kumar, Luisa Viterbo, Hervé Avet-Loiseau, Peter Ganly, Paul G. Richardson, Deborah Berg, Helgi van de Velde, Philippe Moreau, Nikhil C. Munshi, Ludek Pour, Alessandra Di Bacco, S. Vincent Rajkumar, Bin Li, Lei Shen
Publikováno v:
European Journal of Haematology
Objectives: In the TOURMALINE-MM1 phase 3 trial in relapsed/refractory multiple myeloma, ixazomib-lenalidomide-dexamethasone (IRd) showed different magnitudes of progression-free survival (PFS) benefit vs placebo-Rd according to number and type of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26945d840f6982261316ede63224f299
http://hdl.handle.net/11585/804167
http://hdl.handle.net/11585/804167
Autor:
Paul G. Richardson, Yanyan Zhu, Kevin W. Song, Bartrum W Baker, Tamás Masszi, Laura Rosiñol, Tomas Skacel, Huamao Mark Lin, Xavier Leleu, Vladimir Maisnar, Philippe Moreau, Tohru Izumi, Nizar J. Bahlis, Christian Langer, Deborah Berg, Olga Samoilova, Charles S. Cleeland, Peter Gimsing, Luisa Viterbo
Publikováno v:
American Journal of Hematology. 93:985-993
TOURMALINE-MM1 is a phase III, randomized, double-blind, placebo-controlled study of ixazomib plus lenalidomide and dexamethasone (IRd) versus placebo-Rd in patients with relapsed/refractory multiple myeloma following 1-3 prior lines of therapy. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398585393a1184b9345cbd667c3ee248
https://doi.org/10.1002/ajh.25134
https://doi.org/10.1002/ajh.25134
Autor:
Mehdi Hamadani, Irwindeep Sandhu, Helgi van de Velde, Sharon Jackson, Maria-Victoria Mateos, Paul G. Richardson, Ludek Pour, Anne-Marie Stoppa, Gabriela Borsaru, Philippe Moreau, Markus Hansson, Jianchang Lin, Tamás Masszi, Deborah Berg, Alessandra Di Bacco, Peter Gimsing, Luisa Viterbo, Norbert Grzasko
Publikováno v:
Haematologica
Prior treatment exposure in patients with relapsed/refractory multiple myeloma may affect outcomes with subsequent therapies. We analyzed efficacy and safety according to prior treatment in the phase 3 TOURMALINE-MM1 study of ixazomib-lenalidomide-de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d01a8ca953d88e15ea22a01f82e329
http://europepmc.org/articles/PMC5622861
http://europepmc.org/articles/PMC5622861
Autor:
Isabel Oliveira, Ângelo Martins, Susana Lisboa, Cecília Correia, Joana Vieira, Susana Bizarro, Sérgio Chacim, Nuno Cerveira, Rui Santos, Cláudia Moreira, Bruno Loureiro, Lurdes Torres, Jose Mario Mariz, Dulcineia Pereira, Nelson Luís de Campos Domingues, Luisa Viterbo, Ilídia Moreira, Manuel R. Teixeira, Ana Espirito-Santo
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background Most patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) will relapse if treatment is withdrawn, but various trials have recently demonstrated that a significant proportion of patients who achieved a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::313757ab65fee2156faca9c998256570
http://europepmc.org/articles/PMC6292043
http://europepmc.org/articles/PMC6292043
Background Trisodium citrate is an interesting alternative to heparin for the prevention of circuit clotting during extracorporeal procedures, but some protocols require non-commercially available citrate concentrations. Little published information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a3928d819d720e89a5c2b245ddb36c3
http://hdl.handle.net/2318/1634317
http://hdl.handle.net/2318/1634317